Results 111 to 120 of about 1,241,979 (363)

Organization of Specialized Ophthalmo-oncological Care in Moscow

open access: yesOftalʹmologiâ
The purpose: to examine the issue of patient routing for individuals with malignant neoplasms affecting the eye, ocular adnexa, and orbit in Moscow.Material and methods.
G. Sh. Arzhimatova   +3 more
doaj   +1 more source

Sociodemographic, clinical, epidemiological and care aspects of children and adolescents treated for retinoblastoma in Brazil

open access: yesMedicina, 2022
Introduction: Retinoblastoma greatly impacts the affected children and adolescents and their families. Epidemiological approaches to this form of cancer in Brazil are scarce, and this gap motivated this study.
Gabriela Silva Bochi   +6 more
doaj  

Long-term survival in a patient with unresectable liver metastases from uveal melanoma treated with transarterial chemoembolization with irinotecan eluting beads – case report and review of literature

open access: yesContemporary Oncology, 2017
Introduction : Treatment of unresectable liver metastases (LM) from uveal melanoma (UM) remains a major clinical challenge. Systemic chemotherapy and chemoimmunotherapy regimens extrapolated from cutaneous melanoma are considered to be ineffective in ...
Katarzyna Stanisławska   +5 more
doaj   +1 more source

Novel Functional Materials via 3D Printing by Vat Photopolymerization

open access: yesAdvanced Functional Materials, EarlyView.
This Perspective systematically analyzes strategies for incorporating functionalities into 3D‐printed materials via Vat Photopolymerization (VP). It explores the spectrum of achievable functionalities in recently reported novel materials—such as conductive, energy‐storing, biodegradable, stimuli‐responsive, self‐healing, shape‐memory, biomaterials, and
Sergey S. Nechausov   +3 more
wiley   +1 more source

[BANG-polymer dosimetry in the proton therapy of eye neoplasms].

open access: yesZeitschrift fur medizinische Physik, 2004
The use of polymer gel makes it possible to measure three-dimensional dose distributions of ionizing radiation. Phantoms with BANG-1 and BANG-3 gel were irradiated using a 68 MeV proton beam at the eye tumour therapy beam line of the Hahn Meitner Institute in Berlin. Up to twelve treatment fields could be applied to one gel phantom.
Simone, Stiefel   +5 more
openaire   +2 more sources

Laser Engineering of HfN‐Based Nanoparticles for Safe NIR‐I Photothermal and X‐ray Enhancing Cancer Therapies

open access: yesAdvanced Functional Materials, EarlyView.
In this study, we produced HfN‐based nanoparticles via femtosecond laser ablation in acetone. The nanoparticles exhibit a red‐shifted plasmonic resonance in the NIR‐I window, colloidal stability after coating with polyethyleneglycol, and excellent biocompatibility. The photothermal and X‐ray sensitization therapeutic effects were demonstrated for tumor
Julia S. Babkova   +15 more
wiley   +1 more source

A Rare Case of Intraconal Orbital Schwannoma

open access: yesArchives of Medicine and Health Sciences
Schwannoma is a benign, slow-growing peripheral nerve sheath tumor that originates from Schwann cells. Orbital schwannoma is relatively rare, accounting for only 1% of all orbital neoplasms. Intraconal orbital schwannoma (within the muscle cone) is rarer
Savithri Ravindra   +2 more
doaj   +1 more source

Ocular Metastasis in Lung Cancer: a Retrospective Analysis in a Single Chinese Hospital and Literature Review

open access: yesChinese Journal of Lung Cancer, 2017
Background and objective Eye is a rare site of lung cancer metastasis, and ocular metastasis is one of the largest challenges to cancer patients' quality of life (QOL).
Yan XU   +7 more
doaj   +1 more source

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. [PDF]

open access: yes, 2009
BRAF and NRAS are common targets for somatic mutations in benign and malignant neoplasms that arise from melanocytes situated in epithelial structures, and lead to constitutive activation of the mitogen-activated protein (MAP) kinase pathway.
Barsh, Gregory S   +8 more
core  

Home - About - Disclaimer - Privacy